位置:成果数据库 > 期刊 > 期刊详情页
肾透明细胞癌血清差异性蛋白质表达及临床意义研究
  • ISSN号:1007-9572
  • 期刊名称:《中国全科医学》
  • 时间:0
  • 分类:R737.11[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]新疆医科大学第一附属医院泌尿外科,新疆乌鲁木齐市830054
  • 相关基金:国家自然科学基金资助项目(81060210)
中文摘要:

背景与目的利用蛋白质芯片技术寻找肿瘤标志物仍是热点,但目前局限于仅对肾癌患者进行术前、术后的差异性蛋白质检测。为深入检测差异性蛋白质的变化规律,本研究探讨了肾透明细胞癌血清差异性蛋白质表达及临床意义。方法选取2013年11月—2014年4月在新疆医科大学第一附属医院泌尿外科手术治疗并且术后经病理学专家诊断为肾透明细胞癌患者40例为肾癌组,选择同期在本院体检健康志愿者以及非肾癌患者53例为对照组。运用表面增强激光解析电离化飞行时间质谱系统(SELDI - TOF - MS)和 CM10弱阳离子交换蛋白芯片技术系统检测肾癌组及对照组血清差异性蛋白质。应用线性支持向量机(SVM)方法建立蛋白质指纹图诊断模型,留一法交叉验证模型判别效果。通过 ZUCI - PDAS 蛋白质谱数据分析系统软件对血清差异性蛋白质进行分析。结果最终5种蛋白质作为潜在标志蛋白,质荷比(M/ Z)分别为15953、7987、9304、8948、5911,所对应的蛋白质依次为 Bcl -2家族细胞凋亡调节蛋白、WAP 二硫化四物核心蛋白、Krueppel 样因子8、单核细胞趋化蛋白1、血清β-淀粉样蛋白4。肾癌组术前与对照组5种蛋白质表达水平比较,差异有统计学意义(P ﹤0.05)。肾癌组术前与术后1周、1个月、3个月、6个月5种蛋白质表达水平比较,差异均有统计学意义(P ﹤0.05)。术前5种蛋白质表达水平均高于术后1周、1个月、3个月、6个月(P ﹤0.05);术后3、6个月15953、7987蛋白质表达水平与术后1周比较,差异有统计学意义(P ﹤0.05);术后6个月15953、7987蛋白质表达水平与术后3个月比较,差异有统计学意义(P ﹤0.05)。术后1、3、6个月9304、8948、5911蛋白质表达水平与术后1周比较,差异有统计学意义(P ﹤0.05);术后6个月9304、8948、5911蛋白质表达水平与术后1个月比较,差异?

英文摘要:

Background and Objective Looking for tumor markers by using protein chip technology is one of the hot topics,but many studies are still limited to detection of differentiated protein before and after surgery among patients with kidney cancer. In order to detect the variability of differentiated protein,the expression and clinical significance of serum differentiated protein among patients with clear - cell renal cell carcinoma were discussed in this study. Methods 40 patients with clear - cell renal cell carcinoma who underwent surgery in Department of Urology Surgery in the First Affiliated Hospital of Xinjiang Medical University from November 2013 to April 2014,all cases were confirmed by postoperative pathology and were included in kidney cancer group,53 healthy volunteers who underwent medical examination in the same hospital and patients without kidney cancer were included in control group. The surface - enhanced laser desorption ionization time of flight mass spectrometry(SELDI - TOF - MS)and weak cation exchange protein chip(CM10)technology systems were used to identify the serum differentiated protein in kidney cancer group and in control group. The linear support vector machine( SVM)method was used to establish the diagnostic model of protein fingerprints,and the leave - one - out cross validation was used to identify model discrimination effect. The differentially expressed proteins were analyzed by ZUCI - PDAS protein spectral data analysis system software. Results Five kinds of proteins were identified as potential marker protein,the M/ Z of these proteins was 15 953,7 987,9 304, 8 948,5 911,respectively,the corresponding protein was Bcl - 2 family apoptosis regulatory proteins,WAP four - disulfide core protein,Krueppel - like factor 8,monocyte chemotactic protein - 1,serum amyloid β - protein - 4,respectively. There were significant differences in expression levels of five kinds of proteins between kidney cancer group befrore surgery and control group(P ﹤ 0. 05). There were signifi

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国全科医学》
  • 北大核心期刊(2011版)
  • 主管单位:中华人民共和国国家卫生和计划生育委员会
  • 主办单位:中国医院协会 中国全科医学杂志社
  • 主编:韩建军
  • 地址:北京市西城区广义街5号广益大厦A座907
  • 邮编:100053
  • 邮箱:zgqkyx@chinagp.net.cn
  • 电话:010-63052088 83525550
  • 国际标准刊号:ISSN:1007-9572
  • 国内统一刊号:ISSN:13-1222/R
  • 邮发代号:80-258
  • 获奖情况:
  • 获2000-2001年度河北省优秀期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),波兰哥白尼索引,中国中国科技核心期刊,中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:91748